InspireMD Inc (NSPR) has disclosed a new risk, in the Accounting & Financial Operations category.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
InspireMD Inc. faces considerable uncertainty regarding its ability to continue as a going concern, as highlighted in its financial statements for the quarter ended September 30, 2024. The company has been experiencing recurring losses and negative cash flows from its operating activities, which cast doubt on its financial sustainability at current performance levels. This uncertainty is further underscored by an explanatory paragraph in their financial statements, which may hinder InspireMD’s ability to secure new financing under reasonable terms or potentially at all. The ongoing doubts regarding their operational viability could significantly impact the company’s future financial strategies and growth prospects.
Overall, Wall Street has a Moderate Buy consensus rating on NSPR stock based on 1 Buy.
To learn more about InspireMD Inc’s risk factors, click here.
